Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Burlet

Showing results (521-530 of 533) with videos related to

Pageof 54
Sort By:
Science Advances|March 25, 2022
Nuclear HMGB1 protects from nonalcoholic fatty liver disease through negative regulation of liver X receptorJean Personnaz, Enzo Piccolo, Alizée Dortignac, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|June 23, 2023
Real-world evidence: new opportunities for osteoporosis research. Recommendations from a Working Group from the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO)Rebecca J Moon, Jean-Yves Reginster, Nasser M Al-Daghri, et al.
Science Translational Medicine|September 6, 2023
Calprotectin is a contributor to and potential therapeutic target for vascular calcification in chronic kidney diseaseAna Amaya-Garrido, Manon Brunet, Bénédicte Buffin-Meyer, et al.
Aging Clinical and Experimental Research|December 26, 2024
Impact of dementia and mild cognitive impairment on bone health in older peopleElizabeth M Curtis, Mario Miguel, Claire McEvoy, et al.
Nature Reviews. Rheumatology|August 11, 2025
Parathyroid hormone receptor agonists in the management of osteoporosisNicholas Fuggle, René Rizzoli, Charlotte Beaudart, et al.
Research Square|May 27, 2024
<i>De novo</i> designed proteins neutralize lethal snake venom toxinsSusana Vázquez Torres, Melisa Benard Valle, Stephen P Mackessy, et al.
Nature|January 15, 2025
De novo designed proteins neutralize lethal snake venom toxinsSusana Vázquez Torres, Melisa Benard Valle, Stephen P Mackessy, et al.
Drugs|February 19, 2025
Treatment of Osteoporosis and Osteoarthritis in the Oldest OldNicholas Fuggle, Andrea Laslop, René Rizzoli, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|March 28, 2025
Update on the role of bone turnover markers in the diagnosis and management of osteoporosis: a consensus paper from The European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO), International Osteoporosis Foundation (IOF), and International Federation of Clinical Chemistry and Laboratory Medicine (IFCC)Harjit Pal Bhattoa, Samuel Vasikaran, Ioulia Trifonidi, et al.
Nature|October 30, 2025
Nanobody-based recombinant antivenom for cobra, mamba and rinkhals bitesShirin Ahmadi, Nick J Burlet, Melisa Benard-Valle, et al.
Pageof 54

Showing results (521-530 of 533) with videos related to

Sort By:
Pageof 54
Science Advances|March 25, 2022
Nuclear HMGB1 protects from nonalcoholic fatty liver disease through negative regulation of liver X receptorJean Personnaz, Enzo Piccolo, Alizée Dortignac, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|June 23, 2023
Real-world evidence: new opportunities for osteoporosis research. Recommendations from a Working Group from the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO)Rebecca J Moon, Jean-Yves Reginster, Nasser M Al-Daghri, et al.
Science Translational Medicine|September 6, 2023
Calprotectin is a contributor to and potential therapeutic target for vascular calcification in chronic kidney diseaseAna Amaya-Garrido, Manon Brunet, Bénédicte Buffin-Meyer, et al.
Aging Clinical and Experimental Research|December 26, 2024
Impact of dementia and mild cognitive impairment on bone health in older peopleElizabeth M Curtis, Mario Miguel, Claire McEvoy, et al.
Nature Reviews. Rheumatology|August 11, 2025
Parathyroid hormone receptor agonists in the management of osteoporosisNicholas Fuggle, René Rizzoli, Charlotte Beaudart, et al.
Research Square|May 27, 2024
<i>De novo</i> designed proteins neutralize lethal snake venom toxinsSusana Vázquez Torres, Melisa Benard Valle, Stephen P Mackessy, et al.
Nature|January 15, 2025
De novo designed proteins neutralize lethal snake venom toxinsSusana Vázquez Torres, Melisa Benard Valle, Stephen P Mackessy, et al.
Drugs|February 19, 2025
Treatment of Osteoporosis and Osteoarthritis in the Oldest OldNicholas Fuggle, Andrea Laslop, René Rizzoli, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|March 28, 2025
Update on the role of bone turnover markers in the diagnosis and management of osteoporosis: a consensus paper from The European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO), International Osteoporosis Foundation (IOF), and International Federation of Clinical Chemistry and Laboratory Medicine (IFCC)Harjit Pal Bhattoa, Samuel Vasikaran, Ioulia Trifonidi, et al.
Nature|October 30, 2025
Nanobody-based recombinant antivenom for cobra, mamba and rinkhals bitesShirin Ahmadi, Nick J Burlet, Melisa Benard-Valle, et al.
Pageof 54